These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1193415)

  • 21. The immune competence of patients with inflammatory bowel disease.
    Bolton PM; James SL; Newcombe RG; Whitehead RH; Hughes LE
    Gut; 1974 Mar; 15(3):213-9. PubMed ID: 4841278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to cytopathic agents associated with Crohn's disease: a negative study.
    Chiba M; McLaren LC; Strickland RG
    Gut; 1982 Apr; 23(4):333-9. PubMed ID: 7042483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to hookworms in patients with Crohn's disease: a case-control study.
    Kabeerdoss J; Pugazhendhi S; Subramanian V; Binder HJ; Ramakrishna BS
    Aliment Pharmacol Ther; 2011 Oct; 34(8):923-30. PubMed ID: 21848628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of cell-mediated immunity in patients with Crohn's disease.
    Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
    Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
    Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
    Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.
    Auer IO; Götz S; Ziemer E; Malchow H; Ehms H
    Gut; 1979 Apr; 20(4):261-8. PubMed ID: 312753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune status in Crohn's disease. I. Leukocyte and lymphocyte subpopulations in peripheral blood.
    Auer IO; Wechsler W; Ziemer E; Malchow H; Sommer H
    Scand J Gastroenterol; 1978; 13(5):561-71. PubMed ID: 309171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind trial of the use of transfer factor in the treatment of Crohn's disease.
    Vicary FR; Chambers JD; Dhillon P
    Gut; 1979 May; 20(5):408-13. PubMed ID: 381124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leucocyte antigens in Crohn's disease and ulcerative colitis.
    Gleeson MH; Walker JS; Wentzel J; Chapman JA; Harris R
    Gut; 1972 Jun; 13(6):438-40. PubMed ID: 5040832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
    Fujita K; Okabe N; Yao T
    J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
    Bartnik W; Kałuzewski S
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
    Emery P; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Jul; 57(1):123-9. PubMed ID: 6611230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies.
    Meyers S; Sachar DB; Taub RN; Janowitz HD
    Gut; 1978 Apr; 19(4):249-52. PubMed ID: 648933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
    Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
    Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating lymphocyte subpopulations in patients with Crohn's disease].
    Sauer D; Sauer H; Fiebig H
    Gastroenterol J; 1991; 51(1):27-32. PubMed ID: 1910492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell differentiation antigens expressed by peripheral blood lymphocytes in Crohn's disease.
    Pallone F; Squarcia O; Fais S; Boirivant M; Biancone L; Tonietti G
    Boll Ist Sieroter Milan; 1985; 64(5):394-9. PubMed ID: 3937546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.
    Sieber G; Herrmann F; Zeitz M; Teichmann H; Rühl H
    Gut; 1984 Nov; 25(11):1255-61. PubMed ID: 6238880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunological parameters in Crohn's disease].
    Krc I; Kojecký Z; Benýsek L; Matousková I
    Cas Lek Cesk; 1978 Jun; 117(24):733-7. PubMed ID: 679247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.